Dr. Timothy Minh-Tien Dang, MD

Dr. Dang practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Dang's NPI, 1518427913, was assigned on March 21, 2019. Dr. Dang graduated from Stanford University School Of Medicine in 2019. Dr. Dang holds California license A186246.

Dr. Dang's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Dang's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Dang is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dang practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dang is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dang's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, psoriasis, rash, scalp rash and skin cyst among the conditions Dr. Dang treats.

CMS data shows 2,196 Medicare services from Dr. Dang across 15 procedure codes in 2024, for 560 Medicare patients. Medicare paid $120,858 for them.

CMS counts 560 Medicare patients who saw Dr. Dang in 2024. The largest group is 65 to 74, with 251 patients. 67% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dang's median patient age at 60, with 50% women.

In 2024, Dr. Dang wrote 1,483 Medicare Part D claims for 401 patients. 85% of them were for generic drugs. CMS names the drug for 1,298 of them, across 30 drugs with 11 or more claims each, at $1,003,316 in total drug cost. In 2023, CMS named 359 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dang for performance year 2024, reported as part of a group. Dr. Dang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dang as offering telehealth. CMS counts 591 procedures of removal of skin lesions by Dr. Dang, more than 88% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Dang, published from 2023 to 2024. Dr. Dang's most frequent co-authors are Steven Tze-Wei Chen, MD, MPH, Paul Anthony Dejulio, MD and Christopher Ryan Iriarte, MD.

CMS Open Payments shows 20 general payments to Dr. Dang from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 95% of the total. Galderma Laboratories, L.P. paid the most, $521. It also lists 9 research payments totaling $2,191 in 2025, naming 1 clinical trial.

Dr. Dang graduated from Stanford University School Of Medicine in 2019.

Dr. Dang is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.